Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
MDWatch providers are licensed in 35 states, and we open new states every few months
Therefore, one state may approve obesity treatment while another state excludes it or cuts it back
This fundamental difference in treatment duration shapes the entire comparison between these two medications
FDA specifically approves Wegovy for obesity management, while Ozempic and Rybelsus are primarily diabetes medications that doctors prescribe off-label for weight loss
US$ 26.64
US$ 25.58
US$ 22.99
US$ 29.85
US$ 23.44
US$ 29.04
US$ 29.79
